Trials / Completed
CompletedNCT06013137
Chatbot for Depression, Anxiety, and Eating Disorders
Testing an Artificial Intelligence Chatbot for Mental Health
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 210 (actual)
- Sponsor
- Dartmouth-Hitchcock Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The research team would like to test how efficacious an artificial intelligence chatbot is in delivering supportive behavioral interventions in populations with anxiety, depression, or eating concerns.
Detailed description
The research team has developed a deep learning-powered application that can provide support and therapeutic suggestions via natural dialogue. The chatbot is designed to be highly scalable such that it could address access issues (to address the majority of persons who do not not have access to therapy). Eventually, it is hoped this intervention can provide accessible therapy for those with anxiety, depression, and eating disorders, among other mental illnesses. The chatbot has been trained with intervention-oriented text conversations written by research assistants, employing a variety of therapeutic techniques, including cognitive-behavioral therapy. The research team hopes to test how well the chatbot can respond and aid those with mental health symptoms. The chatbot's effectiveness will be monitored based on the participants' interactions with the chatbot, as well as the participants' scores on the PHQ-9, GAD-IV, SWED, and general satisfactory questionnaires.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Therabot | The participants assigned to the experimental group will interact with an artificial intelligence therapy chatbot to alleviate symptoms associated with depression, anxiety, and eating disorders. The control group will not have access to this smartphone chatbot app. |
Timeline
- Start date
- 2024-03-11
- Primary completion
- 2024-05-18
- Completion
- 2024-08-30
- First posted
- 2023-08-28
- Last updated
- 2025-06-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06013137. Inclusion in this directory is not an endorsement.